Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$580M |
| 2 |
Broadcom
AVGO
|
+$511M |
| 3 |
Tesla
TSLA
|
+$471M |
| 4 |
American International
AIG
|
+$438M |
| 5 |
Advanced Micro Devices
AMD
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$444M |
| 2 |
Synopsys
SNPS
|
+$348M |
| 3 |
Pinduoduo
PDD
|
+$326M |
| 4 |
NetEase
NTES
|
+$314M |
| 5 |
DexCom
DXCM
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.37% |
| 2 | Financials | 12.15% |
| 3 | Industrials | 11.37% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Turkcell
TKC
$4.72B
| $114K | ﹤0.01% |
+23,760
| New | +$112K |
|
3552
Toro Corp
TORO
$175M
| $114K | ﹤0.01% |
23,081
+272
| +1% | +$1.23K |
|
|
ASRT
3553
DELISTED
Assertio
ASRT
| $113K | ﹤0.01% |
7,057
-9,590
| -58% | -$237K |
|
3554
Domo
DOMO
$174M
| $113K | ﹤0.01% |
11,005
-2,087
| -16% | -$19.3K |
|
|
MRSN
3555
DELISTED
Mersana Therapeutics
MRSN
| $113K | ﹤0.01% |
1,949
-652
| -25% | -$26.2K |
|
3556
NextNav
NN
$1.83B
| $112K | ﹤0.01% |
25,150
-459,518
| -95% | -$2.08M |
|
3557
Aldeyra Therapeutics
ALDX
$96.5M
| $111K | ﹤0.01% |
31,765
-16,313
| -34% | -$50.3K |
|
3558
Scienjoy Holding
SJ
$42.3M
| $111K | ﹤0.01% |
+31,840
| New | +$89.6K |
|
3559
CorMedix
CRMD
$588M
| $111K | ﹤0.01% |
29,425
-27,964
| -49% | -$96.2K |
|
3560
Codexis
CDXS
$159M
| $109K | ﹤0.01% |
35,681
-2,358
| -6% | -$5.07K |
|
|
PSTX
3561
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $109K | ﹤0.01% |
32,386
+4,722
| +17% | +$12.2K |
|
3562
Cullinan Oncology
CGEM
$1.08B
| $108K | ﹤0.01% |
+10,623
| New | +$94.1K |
|
3563
Zevra Therapeutics
ZVRA
$570M
| $108K | ﹤0.01% |
16,504
+3,133
| +23% | +$14.7K |
|
3564
Inspired Entertainment
INSE
$182M
| $107K | ﹤0.01% |
10,831
-25,114
| -70% | -$237K |
|
3565
NextDecade
NEXT
$1.78B
| $104K | ﹤0.01% |
21,907
+5,641
| +35% | +$26.3K |
|
3566
Vivid Seats
SEAT
$83.2M
| $103K | ﹤0.01% |
812
+163
| +25% | +$22.3K |
|
3567
Organogenesis Holdings
ORGO
$315M
| $102K | ﹤0.01% |
24,863
+2,791
| +13% | +$7.82K |
|
|
CBH
3568
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
| $101K | ﹤0.01% |
11,619
+8
| +0.1% | +$69 |
|
|
ELP
3569
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $101K | ﹤0.01% |
11,943
-29,255
| -71% | -$212K |
|
3570
Shengfeng Development Ltd
SFWL
$84.1M
| $101K | ﹤0.01% |
34,239
-3,829
| -10% | -$42.7K |
|
3571
Nano X Imaging
NNOX
$67.2M
| $100K | ﹤0.01% |
15,766
+3,275
| +26% | +$20.4K |
|
3572
Purple Innovation
PRPL
$31.6M
| $99.5K | ﹤0.01% |
3,863
-339
| -8% | -$8.69K |
|
|
KG
3573
Kestrel Group
KG
$67.1M
| $99.1K | ﹤0.01% |
2,164
+414
| +24% | +$15.3K |
|
3574
Annexon
ANNX
$863M
| $98.8K | ﹤0.01% |
21,772
+3,281
| +18% | +$8.12K |
|
|
ENFN
3575
DELISTED
Enfusion, Inc.
ENFN
| $98.3K | ﹤0.01% |
10,131
-2,116
| -17% | -$19.8K |
|
Similar funds
Invesco's Q4 2023 Portfolio in Review
As of Q4 2023, Invesco held 3,965 positions worth $420B, up 13% from $371B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Invesco's Q4 2023 filing shows 126 new, 1,970 increased, 1,592 reduced and 143 closed positions. Its largest new stake was Veralto: 4,358,553 shares worth $359M. The largest sale was Pioneer Natural Resource Co., an estimated $444M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q4 2023 buy was Veralto: 4,358,553 shares worth $359M.
- Invesco added most to Texas Instruments in Q4 2023, an estimated $580M increase.
- Invesco's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $444M.
- Invesco fully exited Activision Blizzard in Q4 2023, selling an estimated $186M.
- Invesco's ten largest holdings make up 15% of its $420B portfolio in Q4 2023.
- Invesco opened 126 new positions and closed 143 in Q4 2023.
- Invesco's portfolio value rose 13% quarter-over-quarter to $420B.
Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.